Quantcast

Latest Venlafaxine Stories

2008-09-26 09:00:40

Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy. Study results showed that patients new to antidepressant treatment and those who had restarted therapy after a lapse of 6 or more months were twice as likely to discontinue therapy in the first 30 days of treatment versus patients previously dispensed an antidepressant. According to lead author...

68971040a3dc55896c39fbd3fdcb02311
2008-09-23 12:10:00

For some time, antidepressants and other drugs have been used collectively to treat hot flashes and other menopausal symptoms that can accompany breast cancer treatment. However, researchers said on Monday that ancient acupuncture methods work just as well as drugs and their effects tend to outlast drugs. Researchers compared acupuncture, which began in China more than 2,000 years ago, to Wyeth antidepressant Effexor, which is prescribed for hot flashes in breast cancer patients. Dr. Eleanor...

2008-09-11 03:00:08

By Klinger, Gil Merlob, Paul Abstract: Depression is common in women of childbearing age and especially during pregnancy and the postpartum period. Selective serotonin reuptake inhibitors (SSRIs) are increasingly being used to treat depression prior to and throughout pregnancy. Up to 30% of the newborn infants exposed to SSRIs may present with clinical signs during the first days after birth. Neonatal abstinence syndrome (NAS) describes this clinical syndrome resulting from prior prolonged...

2008-07-20 03:00:15

By Raymond, Colette B Wazny, Lori D; Honcharik, Patricia L Depressive disorders occur in up to one-third of patients with chronic kidney disease CKD). First-line pharmacologic treatments include selective serotonin reuptake inhibitors and second generation agents, such as bupropion, mirtazapine, and venlafaxine. Although very little research has been conducted on the use of antidepressants in CKD, health care providers should be aware of renal dose adjustments for these agents, drug...

2008-07-16 18:00:42

MADISON, N.J., July 16 /PRNewswire-FirstCall/ -- Wyeth and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax's proposed generic capsule formulation of Wyeth's EFFEXOR XR(R) antidepressant have been approved by the United States District Court for the District of Delaware. The Court entered a consent judgment resulting in termination of the litigation effective today. Under the terms of the...

2008-07-15 09:01:35

WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's long-term efficacy in preventing recurrence of depressive mood episodes in patients who suffer from major depressive disorder, is the attribute that most influences psychiatrists' prescribing decisions in the treatment of this disorder. Clinical data and expert opinion show that current and emerging therapies...

2008-07-11 12:01:04

By John Sullivan, The Philadelphia Inquirer Jul. 11--Patients taking a popular type of antidepressant are at greater risk for upper gastrointestinal bleeding, according to a new study which appears in the July issue of Archives of General Psychiatry. The risk increases dramatically when the medications, known as selective serontonin reuptake inhibitors, or SSRIs, are combined with drugs that can harm the stomach, such as non-steroidal anti-inflammatory drugs known as NSAIDs, which...

2008-07-10 00:00:28

The U.S. Food and Drug Administration is expected Thursday to recommend black-box warnings on suicide risk for 11 epilepsy drugs. The agency has put warnings about suicidality --suicide risk and suicidal behavior-- on about 35 drugs in the past four years, fueling a debate between groups who say the FDA is overreacting and others who say the risk were ignored previously, The Wall Street Journal reported. The increase in black-box warnings began in 2004 after the FDA was heavily criticized...

2008-07-02 12:01:11

PT. RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate Development. Both Mr. Moore and Ms. Koppy will report to President & Chief Executive Officer Glenn A. Oclassen. "We are pleased to welcome both Terry and Susan to the senior management team at Transcept," said Mr. Oclassen. "Terry's extensive...

2008-06-17 12:00:58

Mylan has announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the FDA for its abbreviated new drug application for Venlafaxine hydrochloride tablets 25mg, 37.5mg, 50mg, 75mg and 100mg. Venlafaxine hydrochloride tablets, indicated for the treatment of major depressive disorder, are the generic version of Wyeth's Effexor tablets. This product is shipping immediately. Currently, Mylan has 92 abbreviated new drug applications pending FDA approval, 20 of...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related